Tuberous sclerosis with recurrent seizure, dermatological lesions, renal cysts, and hypothyroidism in a female patient in Awka, Nigeria

Main Article Content

Ernest Ndukaife Anyabolu
Chinyelu Uchenna Ufoaroh https://orcid.org/0000-0003-4614-482X
Osita Ikenna Okoli
Augustina Ogochukwu Izuu-umeike

Keywords

Tuberous Sclerosis, Ashleaf Lesion, Shagreen Patches, Facial Angiofibroma, Scarring Alopecia, Seizure, Renal Cysts, Hypothyroidism, Awka

Abstract

The incidence of tuberous sclerosis seems to be rising in Nigeria. Tuberous sclerosis with cerebral, renal, thyroid, and dermatological manifestations have not been completely identified. This case report documents a rare case of tuberous sclerosis with cerebral and dermatological lesions, renal cysts, and hypothyroid state. A 28-year-old female patient who presented in our clinic with a history of recurrent seizures for 19 years, a shagreen patch on the right lumbar area, scarring alopecia, and puckering facial angiofibroma. No member of her family had a similar illness. Computerized tomography scan showed multiple echoic cysts in the two kidneys. Her thyroid function tests revealed a hypothyroid state. Brain computerized tomography showed subependymal calcified nodules of the lateral ventricles and prominence of the cerebral sulci, more at the vertex.  Electroencephalogram findings were normal. She was placed on oral Carbamazepine 400mg BD and has remained seizure-free for two years. Tuberous sclerosis with concomitant renal, cerebral, and dermatological lesions and hypothyroidism, though rare, was presented. The patient had tuberous sclerosis with renal cysts, subependymal nodules, and prominence of the cerebral sulci, with recurrent seizures, ash leaf/shagreen patches, scarring scalp alopecia, and a hypothyroid state.    

Abstract 19 | PDF Downloads 19 EPUB Downloads 21

References

1 Northrop H, Krueger DA, Roberds S, Smith K, Sampson J, Korf B,, et al. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4): 243-54.

2 Auldell M, Boronat S, Barber I, Thiele EA. Thyroid nodules on chest CT of patients with tunerous sclerosis complex. Am J Med Genet A. 2015 Dec, 167A(12): 2992-7

3 Mammadova D, Vecko J, Hofmann M, et al. A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex. Orphanet J Rare Dis. 2023; 18: 349.

4 Grilli G, Moffa AP, Perfetto F, Specchiulli LP, Vinci R, Macarini L, Zizzo L. Neuroimaging Features of Tuberous Sclerosis Complex and Chiari Type 1 Malformation: A Rare Association. J Pediatr Neurosci 2018 Apr-Jun; 13(2): 224-228.

5 Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol. 2018 Jun; 93(3): 323-331

6 Franz DN, Capal JK. mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders. Orphanet J Rare Dis 2017 Mar 14; 12(1): 51

7 Luo C, Ye WR, Shi W, et al. Perfect match: mTOR inhibitors and tuberous sclerosis complex. Orphanet J Rare Dis. 2022; 17: 106.

8 Raji YR, Ajayi SO, Enigbokan O, Jinadu OY and Salako BL. Tuberous Complex and Acute Kidney Injury in an Adult Female Nigerian: A rare Presentation and Review of the Literature. Tropical J Nephrol 2012; 6(2):30-37.